These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23259892)

  • 41. HBsAg seroclearance in chronic hepatitis B: implications for hepatocellular carcinoma.
    Kim JH; Lee YS; Lee HJ; Yoon E; Jung YK; Jong ES; Lee BJ; Seo YS; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
    J Clin Gastroenterol; 2011 Jan; 45(1):64-8. PubMed ID: 20535028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Epidemiology of hormone dependent malignant tumors--ovulation inhibitors and liver tumors].
    Bergmann M; Jorke D; Machnik G; Neupert A; Reinhardt M
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(1):30-8. PubMed ID: 3013581
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Molecular biology, diagnosis and treatment of hepatocellular carcinoma].
    Toda G; Okuaki Y
    Nihon Naika Gakkai Zasshi; 1997 Jan; 86(1):146-53. PubMed ID: 9102415
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinicopathological study of juvenile hepatocellular carcinoma with hepatitis B virus infection].
    Kitagawa S; Nakanuma Y; Kaizaki Y
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():381-6. PubMed ID: 15453351
    [No Abstract]   [Full Text] [Related]  

  • 45. Cytokine polymorphisms and hepatocellular carcinoma: to B or not to B.
    Chung RT
    Cancer; 2005 Feb; 103(4):654-6. PubMed ID: 15641028
    [No Abstract]   [Full Text] [Related]  

  • 46. [Comparison of hepatitis B virus and hepatitis C virus seroprevalence in hepatocellular carcinoma].
    Sarr A; Sow AM; Diallo A; Mendez V; Ka Cisse M
    Dakar Med; 1996; Spec No():21-3. PubMed ID: 14520981
    [No Abstract]   [Full Text] [Related]  

  • 47. Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis.
    Shi Y; Wu YH; Wu W; Zhang WJ; Yang J; Chen Z
    Liver Int; 2012 Feb; 32(2):231-40. PubMed ID: 21745272
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical and etiologic features of hepatocarcinoma in Sicily].
    Carroccio A; Soresi M; Bonfissuto G; Magliarisi C; Anastasi G; Vuturo O; Notarbartolo A; Montalto G
    Ann Ital Med Int; 1999; 14(4):233-8. PubMed ID: 10638015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of recurrence in hepatitis B-related hepatocellular carcinoma: impact of viral load in late recurrence.
    Hoshida Y
    J Hepatol; 2009 Nov; 51(5):842-4. PubMed ID: 19748698
    [No Abstract]   [Full Text] [Related]  

  • 50. Posttransplantation hepatitis E: transfusion-transmitted hepatitis rising from the ashes.
    Coilly A; Haïm-Boukobza S; Roche B; Antonini TM; Pause A; Mokhtari C; Becq A; Farahmand H; Hauser L; Duclos-Vallée JC; Samuel D; Adam R; Roque-Afonso AM
    Transplantation; 2013 Jul; 96(2):e4-6. PubMed ID: 23857003
    [No Abstract]   [Full Text] [Related]  

  • 51. Risk of hepatocellular carcinoma in hepatitis B and prevention through treatment.
    Sherman M
    Cleve Clin J Med; 2009 May; 76 Suppl 3():S6-9. PubMed ID: 19465708
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management.
    Cobey FC; Salem RR
    Am J Surg; 2004 Feb; 187(2):181-91. PubMed ID: 14769302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Diagnosis and treatment of hepatocellular carcinoma. Questions for Professor Michel Beaugrand].
    Beaugrand M
    Gastroenterol Clin Biol; 2002 Jan; 26(1):84-6. PubMed ID: 11938047
    [No Abstract]   [Full Text] [Related]  

  • 55. Hepatocellular carcinoma at the cutting edge of science and practice.
    Pellicano R; El-Serag HB; Rizzetto M
    Minerva Med; 2010 Dec; 101(6):391-3. PubMed ID: 21196898
    [No Abstract]   [Full Text] [Related]  

  • 56. [Hepatocellular carcinoma as a rare cause of excessive rise in alpha-fetoprotein in pregnancy].
    Entezami M; Hardt W; Ebert A; Runkel S; Becker R
    Zentralbl Gynakol; 1999; 121(10):503-5. PubMed ID: 10573826
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatocellular carcinoma for the non-specialist.
    Kumagi T; Hiasa Y; Hirschfield GM
    BMJ; 2009 Dec; 339():b5039. PubMed ID: 19965932
    [No Abstract]   [Full Text] [Related]  

  • 58. [The prophylaxis of hepatocellular carcinoma by interferon-alpha in virus-induced cirrhosis].
    Merle P; Zoulim F; Vitvitski L; Trépo C
    Gastroenterol Clin Biol; 2000 Dec; 24(12):1166-76. PubMed ID: 11173729
    [No Abstract]   [Full Text] [Related]  

  • 59. [The natural course of hepatitis B and hepatitis C virus infection].
    Schwabe RF; Stremmel W
    Praxis (Bern 1994); 1998 Oct; 87(42):1403-7. PubMed ID: 9824947
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ruptured hepatocellular carcinoma disguising as heterotopic pregnancy.
    Lee QN; Akra GA; Kigotho AG; Ahadi MS
    BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29487098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.